Skip to main content
. 2015 Oct 13;59(11):7018–7026. doi: 10.1128/AAC.01347-15

FIG 2.

FIG 2

Illustrations of 24-h piperacillin pharmacokinetic profiles following intermittent bolus administration (IA), extended infusion (EI), and continuous infusion (CI) at 16 g/day, 12 g/day, and 8 g/day. Each profile is predicted from the PK model presented in Fig. 1. (A) Predictions for an average patient in the population; (B) prediction for a patient with PK parameters equivalent to the patient with the lowest PK profile in the population. The dotted line represents a MIC of 16 mg/liter.